Blogs

The November 2020 issue of Toxicological Sciences—Volume 178, Issue 1—publishes leading toxicology research in the areas of biomarkers; biotransformation, toxicokinetics, and pharmacokinetics; carcinogenesis; and more.

Two Tox Spotlight articles are featured in the November 2020 issue, publishing research on emerging technologies, methods, and models, as well as regulatory science, risk assessment, and decision-making, respectively:

• “Applicability of hiPSC-Derived Neuronal Cocultures and Rodent Primary Cortical Cultures for In Vitro Seizure Liability Assessment”
• “Leveraging Extraction Testing to Predict Patient Exposure to Polymeric Medical Device Leachables Using Physics-Based Models”

A ToxPoint article discussing “Toxicology Studies on Δ9-tetrahydrocannabinol and Cannabidiol-Containing Products Available to Consumers Are Lacking” also is published in the November 2020 ToxSci issue. ToxPoint pieces are “short, editorial manuscripts making a succinct point regarding emerging areas of toxicology that are particularly timely and important” that “stimulate interest in various areas of toxicology by providing a platform for making a point regarding an opinion, pointing out the significance of recent literature, pointing the way toward new approaches/technologies, or describing the tipping point of controversial subject matter.” Readers are encouraged to join the conversation using the comments feature.

Also included in this issue are two Contemporary Review pieces:

• “Early Life Exposure to Nicotine: Postnatal Metabolic, Neurobehavioral and Respiratory Outcomes and the Development of Childhood Cancers”
• “Mitochondrial Epigenetics and Environmental Health: Making a Case for Endocrine Disrupting Chemicals”

In addition to these featured publications, the November 2020 issue of ToxSci explores immunotoxicology, neurotoxicology, and more.

ToxSci: Your science. Your journal.